Connection

Stefano Rusconi to Cholesterol, HDL

This is a "connection" page, showing publications Stefano Rusconi has written about Cholesterol, HDL.
Connection Strength

0.035
  1. Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data. Ann Pharmacother. 2018 08; 52(8):740-746.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.